Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 144,556 | 178,987 | 138,421 | 118,451 | 351,157 |
| Cost of Goods | 14,027 | 14,184 | 17,300 | 15,476 | 22,264 |
| Gross Profit | 130,529 | 164,803 | 121,121 | 102,975 | 328,893 |
| Operating Expenses | 284,181 | 307,190 | 301,963 | 319,493 | 320,388 |
| Operating Income | -153,625 | -142,203 | -180,542 | -216,042 | 8,769 |
| Interest Expense | 21,177 | 20,384 | 15,585 | 15,717 | 12,815 |
| Other Income | -3,792 | -3,990 | 37,731 | 451 | 3,353 |
| Pre-tax Income | -178,594 | -166,577 | -158,396 | -231,308 | -693 |
| Income Tax | 2,043 | 3,419 | 693 | 803 | 7,135 |
| Net Income Continuous | -180,637 | -169,996 | -159,089 | -232,111 | -7,828 |
| Net Income Discontinuous | -209 | -64 | -293 | -346 | -181,251 |
| Minority Interests | N/A | N/A | 0 | 0 | -233,364 |
| Net Income | $-176,656 | $-170,060 | $-159,382 | $-232,457 | $44,285 |
| EPS Basic Total Ops | -0.74 | -0.72 | -0.68 | -1.00 | 0.25 |
| EPS Basic Continuous Ops | -0.74 | -0.72 | -0.68 | -1.00 | 0.02 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 |
| EPS Diluted Total Ops | -0.74 | -0.72 | -0.68 | -1.00 | 0.25 |
| EPS Diluted Continuous Ops | -0.74 | -0.72 | -0.68 | -1.00 | 0.02 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 |
| EBITDA(a) | $-137,289 | $-125,242 | $-166,370 | $-200,254 | $26,400 |